| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/12/2001 | CA2395892A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114151A1 G protein-coupled receptor agonists or antagonists |
| 07/11/2001 | EP1114060A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 07/11/2001 | EP0822827A4 Antagonists of lhrh |
| 07/11/2001 | CN1303438A Method of cancer diagnosis using chimeric toxin |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303299A Method and compositions for peptide synthesis |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1068334C Schistosome vaccine peptide No.2 |
| 07/10/2001 | US6258933 Process for the one-stage resalting and purification of oligopeptides |
| 07/10/2001 | US6258931 Synthesizing deoxyhypusine derivative by using ester of diprotected lysine, deblocking one nitrogen, condensing with 3-cyanopropanal, reducing to a triamine, protecting free amino groups, deblocking again, and acylating the free amino group |
| 07/10/2001 | US6258782 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/10/2001 | US6258781 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 07/10/2001 | US6258778 Methods for accelerating bone and cartilage growth and repair |
| 07/10/2001 | US6258547 Nucleic acid encoding amp-activated protein kinase |
| 07/10/2001 | CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga |
| 07/10/2001 | CA2047752C Hormone response element compositions and assay |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047556A1 Composition promoting lacrimal secretion |
| 07/05/2001 | WO2001047496A1 Histidine copolymer and methods for using same |
| 07/05/2001 | WO2000078795A3 Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1) |
| 07/05/2001 | WO2000062620A3 Transformed cells useful for the control of pests |
| 07/05/2001 | WO2000035945A8 Cyclic peptide antifungal agents having a sugar substituent |
| 07/05/2001 | WO2000023463A9 Fluorescent dye binding peptides |
| 07/05/2001 | WO1999051625A9 Peptides causing formation of compact structures |
| 07/05/2001 | US20010007037 Solid phase peptide synthesis; in situ generation of amino acid chloride by deblocking; coupling sterically hindered amino acid residues |
| 07/05/2001 | US20010007017 For preventing AIDS or slowing down its progression |
| 07/05/2001 | US20010007015 Can be used as the basic structures (template molecules) for inhibiting and analysing amyloid formation and cytotoxicity in amyloid illnesses |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2394758A1 Histidine-containing copolymers enhance pharmaceutical agent delivery |
| 07/04/2001 | EP1112496A2 Diagnostic method for detecting disturbances of the pancreas |
| 07/04/2001 | EP1112057A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 07/04/2001 | EP0773956B1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
| 07/04/2001 | EP0736038B1 Compounds with growth hormone releasing properties |
| 07/04/2001 | EP0618810B1 Bradykinin antagonist peptides |
| 07/04/2001 | CN1302305A Peptides causing formation of compact structure |
| 07/03/2001 | US6255286 Depsipeptides and drugs containing the same as the active ingredient |
| 07/03/2001 | US6255282 Lytic peptides |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 06/28/2001 | WO2001046415A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | WO2001046223A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | WO2001046222A2 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 06/28/2001 | WO2001046221A1 Protein methylarginine-specific antibodies |
| 06/28/2001 | WO2001046220A2 Bioactive oligopeptides |
| 06/28/2001 | WO2001046125A2 Cd45 inhibitors |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2000075167A9 Phosphorylation assays |
| 06/28/2001 | WO2000070351A3 Protein-protein interactions and methods for identifying them |
| 06/28/2001 | WO2000063236A3 Adhesion modulatory peptides and methods for use |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | WO1997039029A3 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof |
| 06/28/2001 | US20010005747 Bispecific molecules comprising a target cell specific ligand and an effector cell specific antibody or functional antibody fragment |
| 06/28/2001 | CA2395714A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | CA2394877A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | CA2391356A1 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/27/2001 | EP1110086A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 06/27/2001 | EP1109897A1 Method for selecting peptides for the targeted transport of drugs and markers, and peptides discovered using said method |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP0690720B1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/27/2001 | CN1301271A Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 06/27/2001 | CN1301269A Template associated NPY Y2-receptor agonists |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6252040 Administering polypeptide |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251864 Peptides and compounds that bind to a receptor |
| 06/26/2001 | US6251854 N-methyl-d-aspartate receptor channel blockers and method for identifying such |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | US6251364 Ligands with active groups and radioactive materials |
| 06/23/2001 | CA2329487A1 Assay method |
| 06/21/2001 | WO2001044505A2 Methods and kits for discovery of rna-binding antimicrobials |
| 06/21/2001 | WO2001044284A2 Chimeric natriuretic peptides |
| 06/21/2001 | WO2001044274A1 Lipopeptides as antibacterial agents |
| 06/21/2001 | WO2001044273A2 Receptor-selective somatostatin analogs |
| 06/21/2001 | WO2001044272A2 Daptomycin analogs as antibacterial agents |
| 06/21/2001 | WO2001044271A2 Daptomycin analogs and their use as antibacterial agents |
| 06/21/2001 | WO2001043761A2 Methods for treating and preventing damage to mucosal tissue |
| 06/21/2001 | WO2001013110A3 Detection of isomerised epitopes in autoimmune diseases |
| 06/21/2001 | WO2000052036A8 Formation and anion-exchange of crystalline echinocandin ammonium salts |
| 06/21/2001 | WO1998013063A8 Cyclic peptide antitumor agent from an ascidian |
| 06/21/2001 | CA2395585A1 Chimeric natriuretic peptides |
| 06/21/2001 | CA2394350A1 Lipopeptides as antibacterial agents |
| 06/21/2001 | CA2394313A1 Novel lipopeptides as antibacterial agents |
| 06/21/2001 | CA2393907A1 Novel lipopeptides as antibacterial agents |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1107998A2 Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins |
| 06/20/2001 | EP1107982A1 REVERSIBLE BORONATE COMPLEXES OF 1,2-$i(CIS)-DIOL CYCLIC-PEPTIDES |
| 06/20/2001 | EP1107981A2 Ring modified cyclic peptide analogs |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP0889902B1 Antibiotic peptides from bovine milk |
| 06/20/2001 | CN1300320A Assay for the diagnosis of schizophrenia based on a new peptide |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |